PATENT CLAIM ANALYSIS

Application Number: 15911527
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "056000"]

Abstract:
The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.

Claim (Index 5):
The composition of  claim 4  wherein low concentration heparin is in the range of 50 to 1750 units per ml.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.33898
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10979547', '13199605', '14034877', '09763666', '13779637']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.783789766083893
- 35 USC 102 Novelty (BERT): 0.5524840355561726
- Combined Prediction Score: 0.7606591930311208
- Mean Citation Score: 325.356508
- Max Citation Score: 410.8273
- Similarity Product: 357.7565011435151

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test